Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

May 16, 2025

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

News Daily News

IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC

Michael O'Riordan

November 11, 2024

October 2023 News Roundup

News Opinion CV Team Dispatch

October 2023 News Roundup

October 01, 2023

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

August 30, 2022

PAD Significantly Ups Morbidity and Mortality in AMICS

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

March 29, 2022

July/August 2021 News Roundup

News Opinion CV Team Dispatch

July/August 2021 News Roundup

August 01, 2021

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

News Daily News

US Data Convey the Scope of Bleeding in Lower-Extremity Peripheral Interventions

June 18, 2019

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

News Features

Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients?

May 01, 2019

News Daily News

尽管无证据支持疗效，每 6 例患者中仍有 1 例接受腔静脉过滤器

Yael L. Maxwell

February 29, 2016

News Daily News

Incluso Sin Prueba de Beneficio, 1 de cada 6 Pacientes Reciben Filtros de la Vena Cava

Yael L. Maxwell

February 29, 2016

News Daily News

Even Without Proof of Benefit, 1 in 6 Patients Still Given Vena Caval Filters

Yael L. Maxwell

February 29, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.